Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Ariad Pharmaceuticals Inc (NASDAQ:ARIA.DL)

CAPS Rating: No stars

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ARIA.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

shaneatlas (46.58)
Submitted October 09, 2013

oversold

PDTBiotech (70.80)
Submitted March 21, 2012

Very rich valuation + unimpressive pipeline + stock went up (???) following 13-1 thrashing of ridaforolimus as maintenance therapy for patients with mSTS by ODAC.

NASDAQ:ARIA.DL VS S&P 500 (SPY)

NASDAQ:ARIA.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about ARIA.DL.

No one has written a Pitch for ARIA.DL stock yet. Tell us why you think ARIA.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in ARIA.DL.

No players have picked ARIA.DL yet. Tell us why you think ARIA.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ARIA.DL.